Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis
Yao Jin, Jiayan Wei, Yiming Weng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9

Showing 9 citing articles:

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
Karen Abboud, Godsfavour Umoru, Abdullah Esmail, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1433-1433
Open Access | Times Cited: 13
Dendritic cells-targeted delivery of mRNA vaccines and dual siRNAs via microneedles effectively inhibits tumor growth
Yifei Pei, Zhen Chen, Xiaoyun Wang, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106768-106768
Closed Access
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly
Jacob J. Adashek, Jillian A. Moran, Dung T. Le, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
PD‐L1 regulates tumor proliferation and T‐cell function in NF2‐associated meningiomas
Ying Wang, Chao Zhang, Minjun Yan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 3
Targeted delivery of T-cell agonists for enhancing immunotherapy
Ling Mao, Mengfei Yin, Congfei Ji, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105074-105074
Closed Access | Times Cited: 3
Evaluating the benefit of immunotherapy for stage III melanoma
Amar D. Desai, Sarah J. Ibrahim, Faramarz H. Samie
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 3, pp. 521-522
Closed Access
Immune checkpoint inhibitor-induced cholangitis—a three-case series
Simon Gray, Nuria Santamaría, Anna Olsson‐Brown
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 818-825
Open Access
Expression of the Extracellular Domain of Mouse PD-L1 and Production of Antibodies to PD-L1
Marina Goryunova, D. Yu. Ryazantsev, E. E. Petrova, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 6, pp. 2644-2656
Closed Access
Expression of extracellular fragment of murine PD-L1 and production of antibodies to PD-L1
Marina Goryunova, D. Yu. Ryazantsev, E. E. Petrova, et al.
Биоорганическая химия (2024) Vol. 50, Iss. 6, pp. 871-882
Closed Access
Construction of a ferroptosis-related lncRNA signature for predicting prognosis, immune response and drug sensitivity in cervical squamous cell carcinoma and endocervical adenocarcinoma
Tingting Gu, Caihong Xu, Jing Chen, et al.
European Journal of Gynaecological Oncology (2023) Vol. 44, Iss. 6, pp. 29-29
Open Access
Page 1

Scroll to top